Human prostate cancer precursors and pathobiology

Area of Science:

• Oncology
• Molecular Biology
• Urology

Background:

• Prostate cancer is a common malignancy with poorly understood molecular mechanisms.
• Chronic inflammation, atrophy, and genetic instability are implicated in prostate carcinogenesis.
• Oxidants, electrophiles, and specific gene expressions play roles in disease development.

Purpose of the Study:

• To review new information on the roles of oxidants, electrophiles, inflammation, and genetic factors in prostate cancer.
• To explore alpha-methylacyl-coenzyme A racemase (AMACR) as a potential marker for prostate carcinogenesis.
• To understand the molecular pathways from proliferative inflammatory atrophy (PIA) to prostate cancer.

Main Methods:

• Review of current literature on prostate cancer etiology and molecular mechanisms.
• Analysis of the roles of specific proteins like p27(Kip1), Bcl-2, GSTP1, and AMACR.
• Investigation of cellular processes including inflammation, cell death, proliferation, and gene methylation.

Main Results:

• Prostate cancer may arise from proliferative inflammatory atrophy (PIA), driven by inflammation and cell death.
• Decreased p27(Kip1) and increased Bcl-2 are associated with proliferation and reduced apoptosis in PIA.
• Aberrant methylation of GSTP1 promoter silences its expression, facilitating genetic damage and cancer progression.
• AMACR shows potential as a marker for prostate cancer, possibly enhanced by p63 staining.

Conclusions:

• Inflammation and oxidative stress contribute to prostate cancer development through complex molecular pathways.
• GSTP1 gene silencing via methylation is a critical step in prostate carcinogenesis.
• AMACR, in conjunction with p63, offers a promising avenue for improved prostate cancer detection.